Embracing uncertainty and finding strength in adversity are crucial for personal growth and resilience during a cancer ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

A breast cancer survivor finds support and friendship through an online group, easing her journey post-diagnosis. The ...

Cortes discussed the evolution of chronic myeloid leukemia treatment and emerging strategies aimed at improving outcomes and quality of life. Dr. Jorge E. Cortes sat down with CURE to discuss the ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

Neuroendocrine tumors originate from neuroendocrine cells, often presenting as slower-growing compared to other cancers like ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Today, HRT is recognized as essential. Key takeaways: It helps with more than hot flashes, supporting bone, heart and brain ...

The FDA's fast track designation aims to expedite ITM-94's development for diagnosing clear cell renal cell carcinoma. The ...